The V-Go Disposable Insulin Delivery Device gets the FDA Nod of Approval
The V-Go disposable insulin delivery device for the continuous subcutaneous (a subcutaneous injection, a needle is inserted just under the skin. A drug (for example, insulin) can then be delivered into the subcutaneous tissues. After the injection, the drug moves into small blood vessels and the bloodstream.) The delivery of the insulin has preset basal rates and with on-demand bolus dosing for adult patients requiring insulin.
The V-Go disposable insulin delivery device will be available in a preset basal rate to deliver 20, 30 or 40 Units of insulin in one 24-hour period. In addition, and on-demand bolus dosing in 2 Unit increments (up to 36 Units per one 24-hour time period) will also be available.
About the V-Go Device
The V-Go is the first disposable device for the delivery of basal-bolus insulin therapy for adults with diabetes. The V-Go provides a continuous preset basal rate of insulin and allows for on-demand bolus dosing around mealtimes. This device provides diabetics with an alternative to taking multiple daily insulin injections.